home / stock / mycof / mycof news

MYCOF News and Press, New Age Brands From 07/13/21

Stock Information
Company Name: New Age Brands
Stock Symbol: MYCOF
Market: OTC
Website: mydecine.com
Menu
MYCOF MYCOF Quote MYCOF Short MYCOF News MYCOF Articles MYCOF Message Board
Get MYCOF Alerts

News, Short Squeeze, Breakout and More Instantly...
MYCOF - Mydecine's Prospects Look Magical, Like A Mushroom

The company is developing molecules based on psilocybin to treat PTSD and also has an app for psychedelic after-care remote therapy. Mydecine is the first company in the world to complete an international legal export of dried magic mushrooms. The future for psychedelic-assisted t...
MYCOF - Mydecine: Innovative Solutions for Treating Mental Health

Any time you have an emerging sector like psychedelic medicine, where every week new players are going public, it’s hard to determine who has real substance, a real infrastructure and real potential. On June 22, 2021, Mydecine Innovations Group Inc. separated itself from the ...

MYCOF - Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004

DENVER, June 24, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative ...

MYCOF - Mydecine to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th

DENVER, June 23, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative ...
MYCOF - Mydecine Unveils Artificial Intelligence Drug Discovery Program

DENVER, June 16, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative ...

MYCOF - Mydecine Discovers 40 New Compounds In Mushrooms

Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) reports that its R&D team has discovered over 40 compounds with pharmacological potential in mushrooms. Mydecine said that it has screened over 25 mushroom species, including various varieties of p. cubensis, and...

MYCOF - Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms

DENVER, June 08, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative ...
MYCOF - Mydecine to Participate in the H.C. Wainwright Psychedelics in Psychiatry and Beyond Conference on June 17th

DENVER, June 03, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative ...

MYCOF - Mydecine gets Health Canada approval for psilocybin related cultivation expansion

Mydecine Innovations (MYCOF) has received approval from Health Canada to expand its cultivation capabilities at the company's Canadian Current Good Manufacturing Practice ((cGMP)) facility at Applied Pharmaceutical Innovation ((API)).Under the new guidance from Health Canada, Mydecine will be...

MYCOF - Health Canada Approves Expansion of Mydecine's Cultivation Capabilities for Psilocybin Producing Mushrooms

DENVER, May 25, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-so...
Previous 10 Next 10